JNJ Begins Drug Sector Q2 Earnings With a Beat & Guidance Raise

• click to rate

  Posted by Two Blokes Jul 16 - Filed in Stock - 1 view
  
  JNJ tops second-quarter estimates and raises 2025 guidance as Innovative Medicines outperforms and MedTech gains momentum.